Pfizer CEO Bourla Says Company Looking For ‘Superior’ Results from Weight-Loss Drugs

Pfizer CEO Albert Bourla told Bloomberg’s Katie Greifeld Pfizer is looking for ‘superior results’ while developing and testing further GLP-1 weight loss medications in a crowded market. Bourla also commented on his company’s relationship with the Trump administration as businesses look for stability on pricing and tariffs. He told Bloomberg he is optimistic that uncertainty […]

Semaglutide Attenuates Neuroinflammation in Mice

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have shown promise in preclinical models of neurodegeneration, with emerging evidence suggesting these effects may be driven by modulation of neuroinflammation. However, the cellular mechanisms underlying GLP-1 RA effects on neuroinflammation remain poorly understood. Here, using a mouse model of lipopolysaccharide-induced neuroinflammation, we investigated how semaglutide coordinates cellular responses […]

Tom Brady joins telehealth startup to help sell GLP-1s

Of all the television personalities on GLP-1s like Ozempic, Tom Brady doesn’t appear to be one of them. You don’t play in the NFL into your mid-40s if you need help losing a few pounds. But the Fox Sports commentator will now be the new “face” of GLP-1s, at least according to a headline by […]